ConductScience.org, home

Paper35936719

A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.

Ahmed S and 6 others. Front Oncol, 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma. Papers, record 35936719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35936719

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.
PubMed
Journal
Front Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2024-09-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahmed SSarfraz
2Mobashir MMohammad
3Al-Keridis LALamya Ahmed
4Alshammari NNawaf
5Adnan MMohd
6Abid MMohammad
7Hassan MIMd Imtaiyaz

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124092244A review on pharmacological and analytical aspects of diosmetin: a concise report.Chin J Integr Med2013https://conductscience.org/library/papers/24092244PubMed
229622463Genomic and Functional Approaches to Understanding Cancer Aneuploidy.Cancer Cell2018https://conductscience.org/library/papers/29622463PubMed
323774734Alternative cleavage and polyadenylation: extent, regulation and function.Nat Rev Genet2013https://conductscience.org/library/papers/23774734PubMed
421753790Advances in sarcoma genomics and new therapeutic targets.Nat Rev Cancer2011https://conductscience.org/library/papers/21753790PubMed
529625055An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.Cell2018https://conductscience.org/library/papers/29625055PubMed
626691984Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations.Nat Genet2016https://conductscience.org/library/papers/26691984PubMed
725230880Integrative oncology: really the best of both worlds?Nat Rev Cancer2014https://conductscience.org/library/papers/25230880PubMed
824763618The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression.Mol Biosyst2014https://conductscience.org/library/papers/24763618PubMed
919246318Global networks of functional coupling in eukaryotes from comprehensive data integration.Genome Res2009https://conductscience.org/library/papers/19246318PubMed
1016426740Cancer: a Systems Biology disease.Biosystems2006https://conductscience.org/library/papers/16426740PubMed
1138217166Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies.Nat Comput Sci2021https://conductscience.org/library/papers/38217166PubMed
1224492837Cancer Systems Biology: a peek into the future of patient care?Nat Rev Clin Oncol2014https://conductscience.org/library/papers/24492837PubMed
1328725462A differential network analysis approach for lineage specifier prediction in stem cell subpopulations.NPJ Syst Biol Appl2015https://conductscience.org/library/papers/28725462PubMed
1414594945MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.J Biol Chem2004https://conductscience.org/library/papers/14594945PubMed
1521376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1618091723A map of human cancer signaling.Mol Syst Biol2007https://conductscience.org/library/papers/18091723PubMed
1734448628Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.OMICS2021https://conductscience.org/library/papers/34448628PubMed
1817354233Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.Int J Cancer2007https://conductscience.org/library/papers/17354233PubMed
1933927693In-Silico Study of Immune System Associated Genes in Case of Type-2 Diabetes With Insulin Action and Resistance, and/or Obesity.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/33927693PubMed
2024446173Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli.Appl Biochem Biotechnol2014https://conductscience.org/library/papers/24446173PubMed

See all 81 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
39567714Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation.Sci Rep2024https://conductscience.org/library/papers/39567714PubMed
39480853Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug.PLoS One2024https://conductscience.org/library/papers/39480853PubMed
39342545
β-Citronellol: a potential anti-inflammatory and gastro-protective agent-mechanistic insights into its modulatory effects on COX-II, 5-LOX, eNOS, and ICAM-1 pathways through in vitro, in vivo, in silico, and network pharmacology studies.
Inflammopharmacology2024https://conductscience.org/library/papers/39342545PubMed
39065790Pharmacogenomics: A Genetic Approach to Drug Development and Therapy.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39065790PubMed
39023830Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.Apoptosis2024https://conductscience.org/library/papers/39023830PubMed
38984575Exploring the Mechanism of Shen Qi Gui Oral Liquid against Chemotherapy- Induced Myelosuppression in Cancer Patients Based on Network Pharmacology and Molecular Docking.Comb Chem High Throughput Screen2025https://conductscience.org/library/papers/38984575PubMed
38911744Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.ACS Omega2024https://conductscience.org/library/papers/38911744PubMed
38301049Interaction of Sp1 and Setd8 promotes vascular smooth muscle cells apoptosis by activating Mark4 in vascular calcification.Aging (Albany NY)2024https://conductscience.org/library/papers/38301049PubMed
38054921Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.Int J Immunopathol Pharmacol2023https://conductscience.org/library/papers/38054921PubMed
38004413Cleomin Exerts Acute Antinociceptive Effects in Mice via GABAB and Muscarinic Receptors.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38004413PubMed
36675976Role of ZNF143 and Its Association with Gene Expression Patterns, Noncoding Mutations, and the Immune System in Human Breast Cancer.Life (Basel)2022https://conductscience.org/library/papers/36675976PubMed
36552885An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation.Cells2022https://conductscience.org/library/papers/36552885PubMed
36479247Genomic profiling and network-level understanding uncover the potential genes and the pathways in hepatocellular carcinoma.Front Genet2022https://conductscience.org/library/papers/36479247PubMed
36430361Transcription Factors as Targets of Natural Compounds in Age-Related Diseases and Cancer: Potential Therapeutic Applications.Int J Mol Sci2022https://conductscience.org/library/papers/36430361PubMed
36232319Synthesis of Silver Nano Particles Using Myricetin and the In-Vitro Assessment of Anti-Colorectal Cancer Activity: In-Silico Integration.Int J Mol Sci2022https://conductscience.org/library/papers/36232319PubMed

Download CSV of cited by

Genes97

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCC14363PubTator's text mininghttps://conductscience.org/library/genes/4363NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALPK180216PubTator's text mininghttps://conductscience.org/library/genes/80216NCBI Gene
ARFGEF210564PubTator's text mininghttps://conductscience.org/library/genes/10564NCBI Gene
ARHGEF29181PubTator's text mininghttps://conductscience.org/library/genes/9181NCBI Gene
ARID3A1820PubTator's text mininghttps://conductscience.org/library/genes/1820NCBI Gene
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
BICRA29998PubTator's text mininghttps://conductscience.org/library/genes/29998NCBI Gene
BLOC1S3388552PubTator's text mininghttps://conductscience.org/library/genes/388552NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CAMK2B816PubTator's text mininghttps://conductscience.org/library/genes/816NCBI Gene
CCDC9790324PubTator's text mininghttps://conductscience.org/library/genes/90324NCBI Gene
CCNH902PubTator's text mininghttps://conductscience.org/library/genes/902NCBI Gene
CCNT1904PubTator's text mininghttps://conductscience.org/library/genes/904NCBI Gene
CDC42998PubTator's text mininghttps://conductscience.org/library/genes/998NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK51020PubTator's text mininghttps://conductscience.org/library/genes/1020NCBI Gene
CDK71022PubTator's text mininghttps://conductscience.org/library/genes/1022NCBI Gene

See all 97 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35936719

GET https://conductscience.org/api/papers/v1/35936719/references?page=2